CSIMarket Company Name, Ticker, Competitors, else..


Point Biopharma Global Inc   (NASDAQ: PNT)
Other Ticker:  
 

Point Biopharma Global Inc

PNT's Fundamental analysis



Looking into Point Biopharma Global Inc growth rates, revenue grew in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 2910

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.76 %

Point Biopharma Global Inc net loss increased from $-24 millions, to $-25 millions in III. Quarter 2023,

• More on PNT's Growth


Point Biopharma Global Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Point Biopharma Global Inc PEG ratio is at -0.17 Point Biopharma Global Inc realized cash reduction of $ -0.98 per share in trailing twelve-month period.
Company
25.73
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.43.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.


• More on PNT's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 2,436,927
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 4.01

Point Biopharma Global Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Point Biopharma Global Inc PEG ratio is at -0.17 Point Biopharma Global Inc realized cash outflow of $ -0.98per share in trailing twelve-month period.
Company
25.73
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.43.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.

Point Biopharma Global Inc Price to Book Ratio is at 3.12 lower than Industry Avg. of 77.28. and higher than S&P 500 Avg. of 0.01

• More on PNT's Valuation

•  Market Capitalization (Millions $) 1,322
•  Shares Outstanding (Millions) 106
•  Employees 100
•  Revenues (TTM) (Millions $) 244
•  Net Income (TTM) (Millions $) 97
•  Cash Flow (TTM) (Millions $) -104
•  Capital Exp. (TTM) (Millions $) -19
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 2,436,927
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 4.01

•  Market Capitalization (Millions $) 1,322
•  Shares Outstanding (Millions) 106
•  Employees 100
•  Revenues (TTM) (Millions $) 244
•  Net Income (TTM) (Millions $) 97
•  Cash Flow (TTM) (Millions $) -104
•  Capital Exp. (TTM) (Millions $) -19





  Ratio
•   Capital Ratio (MRQ) 9.14
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.13
•  Asset Turnover Ratio (TTM) 0.49
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com